ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the incremental benefit over an angiography-guided approach alone. This question is particularly relevant in the DK crush technique, which involves multiple steps in which procedural optimization—especially the rewiring step—may be critical to the effectiveness of the technique.

Cobertura Científica SOLACI ACC 2026

The aim of the DKCRUSH VIII study was to investigate the effect of an IVUS-guided PCI strategy compared with an angiography-guided PCI in patients with true complex coronary bifurcation lesions.

A randomized study was conducted across 24 centers in China, enrolling 556 patients, with 278 assigned to IVUS-guided DK crush and 278 to angiography-guided DK crush. Patients older than 18 years with truly complex bifurcations were included, defined—among other criteria—by a side branch lesion ≥10 mm, side branch ostial stenosis of 70% to 90%, plus two minor criteria, and MV-QFR ≤0.8.

The primary endpoint (PFP) was target vessel failure (TVF) at 12 months, defined as a composite of cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularization.

The mean age was 67 years, and 77.3% of patients were male. Most patients presented with unstable angina, and approximately 18% with STEMI. From an anatomical and procedural standpoint, nearly half involved distal left main bifurcations; radial access was predominant, and the DK crush technique was used in 96.8% of both groups.

Read also: ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery.

At 1-year follow-up, the primary endpoint occurred in 6.1% of the IVUS group and 14.7% of the angiography-guided group (HR 0.40; 95% CI 0.23–0.71; p=0.0016). Reductions were also observed in several clinical components: target vessel MI in 4.3% vs 9.4% (HR 0.46; p=0.02), spontaneous MI in 1.8% vs 6.1% (HR 0.29; p=0.01), and TVR in 2.9% vs 7.6% (HR 0.37; p=0.02). There were no significant differences in all-cause mortality (1.4% vs 1.1%; p=0.70), cardiac death (0.7% vs 1.1%; p=0.66), or definite/probable stent thrombosis (0.4% vs 1.1%; p=0.38).

Systematic IVUS evaluation identified relevant procedural findings, including incomplete crushing in 28.2%, distal rewiring after the first rewiring in 41.5%, and suboptimal diameter after final POT in 61.0% of evaluated patients.

Read also: ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation.

An additional exploratory analysis showed that when IVUS-defined optimization criteria were achieved, the TVF rate was 2.6%, compared with 15.9% in suboptimal PCI and 14.7% in the angiography-guided arm.

Conclusions: IVUS significantly reduces target vessel failure in complex coronary bifurcations treated with DK crush

In this randomized study, IVUS-guided DK crush was associated with a lower rate of TVF at one year compared with angiography-guided PCI in complex coronary bifurcations. This benefit was primarily driven by achieving IVUS-defined optimization targets rather than by the mere use of IVUS.

Presented by Shao-Liang Chen at the Late-Breaking Clinical Trials, ACC.26, March 28–30, New Orleans, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...